| Sector |
Healthcare
|
Compare with Sector peers |
| Industry |
Pharmaceuticals & Drugs
|
Compare with Industry peers |
| Website | http://www.sandu.in | |
| Market Cap | 59.22 Cr. | |
| Enterprise Value(EV) | 54.98 Cr. | 2023-09 |
| Financial Indicators | ||
|---|---|---|
| Earnings per share (EPS) | 1.18 | Trailing Twelve Months Ending 2023-12 |
| Price-Earning Ratio (PE) | 52.04 | Trailing Twelve Months Ending 2023-12 |
| Industry PE | 41.99 | Trailing Twelve Months Ending 2023-12 |
| Book Value / Share | 32.73 | Trailing Twelve Months Ending 2023-12 |
| Price to Book Value | 1.87 | Calculated using Price: 61.30 |
| Dividend Yield | 1.22 | Period Ending 2023-03 |
| No. of Shares Subscribed | 0.97 Cr. | 9,660,990 Shares |
| FaceValue | 10 | |
| About Sandu Pharmaceuticals Ltd. | ||
| Sandu Pharmaceuticals incorporated in 1985, is engaged in manufacturing of ayurvedic medicines. The company operates a distribution network in India as well as in the overseas markets. | ||
| 1 Day |
|
-1.97% |
| 1 Week |
|
|
| 1 Month |
|
+2.81% |
| 3 Month |
|
-12.15% |
| 6 Month |
|
-0.40% |
| 1 Year |
|
+7.97% |
| 2 Year |
|
-24.51% |
| 5 Year |
|
+185.88% |
| 10 Year |
|
+601.70% |
| 1 years | 2023-03 | |
| Return on Equity (%) | 5 | |
| Return on Capital Employed (%) | 7.55 | |
| Return on Assets (%) | 2.81 |
| Particulars | 2 years | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
| Shh. Funds | 39 | 40 | |
| Non Curr. Liab. | 1 | 1 | |
| Curr. Liab. | 14 | 12 | |
| Minority Int. | |||
| Equity & Liab. | 54 | 53 | |
| Non Curr. Assets | 29 | 28 | |
| Curr. Assets | 26 | 25 | |
| Misc. Exp. not W/O | |||
| Total Assets | 54 | 53 |
| Particulars | 2 years | 2023-03 Rs. Cr. | 2023-12 Rs. Cr. TTM |
| Net Sales | 65 | 67 | |
| Other Income | 0 | 0 | |
| Total Income | 66 | 67 | |
| Total Expenditure | -63 | -65 | |
| PBIDT | 3 | 2 | |
| Interest | 0 | 0 | |
| Depreciation | -1 | -1 | |
| Taxation | -1 | -1 | |
| Exceptional Items | |||
| PAT | 2 | 1 | |
| Minority Interest | |||
| Share Associate | |||
| Other Related Items | |||
| Consolidated Net Profit | 2 | 1 | |
| Adjusted EPS | 2 | 1 |
| Particulars | 1 years | 2023-03 Rs. Cr. |
| Cash Fr. Operatn. | 0 | |
| Cash Fr. Inv. | 1 | |
| Cash Fr. Finan. | 1 | |
| Net Change | 1 | |
| Cash & Cash Eqvt | 2 |
|
Thu, 25 Apr 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate stop transfer for duplicate issue of share certificate |
|
Wed, 24 Apr 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Stop Transfer for Duplicate issue of Share Certificate |
|
Wed, 17 Apr 2024
Compliance Under Regulation 40(9) Of SEBI (LODR) Compliance under Regulation 40(9) for the Year ended 31st March 2024 |
| Fri, 26 Apr 2024 |
High Delivery Percentage
|
Opening at High
|
Closing Below Previous Low
|
High Decrease in 3 Months
|
High Increase in 5 Years
|
